Related Experiment Video

Updated: Jul 30, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection

K Csencsits1, S C Wood, G Lu

  • 1Section of General Surgery, Department of Surgery, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|April 14, 2006
PubMed

Insights

Chronic rejection (CR) of organ transplants lacks effective treatments. This study identifies connective tissue growth factor (CTGF) as a key mediator, suggesting it as a potential therapeutic target for CR.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Molecular Medicine

Background:

  • Late allograft dysfunction is primarily caused by chronic rejection (CR), a process with unknown etiology and no effective treatments.
  • Understanding the molecular mechanisms underlying CR is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the roles of transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) in the development of chronic rejection.
  • To compare the molecular events in cardiac allografts undergoing CR versus those that do not.

Main Methods:

  • Comparison of cardiac allografts in mice treated with anti-CD4 therapy (developing CR) versus anti-CD40L therapy (not developing CR).
  • Analysis of TGF-beta and CTGF expression in allografts.
  • Experimental induction of CR by TGF-beta transfection in anti-CD40L-treated recipients and syngeneic grafts.

Main Results:

  • Transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) were expressed in grafts with CR but not in grafts without CR.
  • TGF-beta transfection induced CTGF expression and CR in allografts, but not in syngeneic grafts, indicating antigenic stimulation is required.
  • TGF-beta alone was insufficient to induce CR; CTGF is essential.

Conclusions:

  • Connective tissue growth factor (CTGF) is a critical mediator in the development of chronic rejection.
  • Antigenic stimulation is necessary for TGF-beta to induce CTGF production.
  • CTGF represents a promising therapeutic target for preventing or treating chronic rejection.

More Related Videos

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...